Arrhythmias, Cardiac

Cardiovascular
0
Pipeline Programs
5
Companies
11
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Rhythm Pharmaceuticals
5 programs
Arrhythmia MappingN/A1 trial
Insertion of ILR deviceN/A1 trial
Reveal LINQN/A1 trial
Reveal® DX or Reveal® XT Insertable Cardiac MonitorN/A1 trial
cardiac implantable electronic devicesN/A1 trial
Active Trials
NCT06939478Recruiting110Est. Dec 2025
NCT04471584Unknown150Est. Mar 2022
NCT02746471Completed1,604Est. Jun 2021
+2 more trials
Biotronik
BiotronikGermany - Berlin
3 programs
BIOTRONIK ICDs with DX TechnologyN/A1 trial
SIELLO JT/TN/A1 trial
remote monitoringN/A1 trial
Active Trials
NCT04869527Active Not Recruiting50Est. Apr 2025
NCT01000532Completed88Est. Feb 2011
NCT04557111Completed102Est. Dec 2022
Elutia
ElutiaSILVER SPRING, MD
1 program
CanGaroo EnvelopeN/A1 trial
Active Trials
NCT04846127CompletedEst. Oct 2024
Stereotaxis
StereotaxisST.LOUIS, MO
1 program
MAGiC™N/A1 trial
Active Trials
NCT06019845Recruiting150Est. Sep 2026
Beacon Therapeutics
Beacon TherapeuticsMA - Cambridge
1 program
PulseAI ECG PlatformN/A1 trial
Active Trials
NCT05668377UnknownEst. Jan 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Rhythm PharmaceuticalsArrhythmia Mapping
StereotaxisMAGiC™
Beacon TherapeuticsPulseAI ECG Platform
Rhythm Pharmaceuticalscardiac implantable electronic devices
BiotronikBIOTRONIK ICDs with DX Technology
ElutiaCanGaroo Envelope
Biotronikremote monitoring
Rhythm PharmaceuticalsInsertion of ILR device
Rhythm PharmaceuticalsReveal LINQ
Rhythm PharmaceuticalsReveal® DX or Reveal® XT Insertable Cardiac Monitor
BiotronikSIELLO JT/T

Clinical Trials (11)

Total enrollment: 3,320 patients across 11 trials

NCT06939478Rhythm PharmaceuticalsArrhythmia Mapping

AI Powered Mapping Technology for Identifying Arrhythmias

Start: Aug 2025Est. completion: Dec 2025110 patients
N/ARecruiting
NCT06019845StereotaxisMAGiC™

The MAGiC™ Cardiac Ablation European Study

Start: Jan 2024Est. completion: Sep 2026150 patients
N/ARecruiting
NCT05668377Beacon TherapeuticsPulseAI ECG Platform

Automated Diagnostic Performance of Smartwatch ECG for Arrhythmia Detection Using the PulseAI Neural Network.

Start: Jan 2023Est. completion: Jan 2024
N/AUnknown
NCT05061862Rhythm Pharmaceuticalscardiac implantable electronic devices

Cardiac Implantable Electronic Device (CIED) Research Study

Start: Mar 2022Est. completion: May 20261,000 patients
N/AActive Not Recruiting
NCT04869527BiotronikBIOTRONIK ICDs with DX Technology

Full Early Atrial Diagnostics in Single Chamber ICD Patients Using the DX Lead and Home Monitoring in Brazil.

Start: Oct 2021Est. completion: Apr 202550 patients
N/AActive Not Recruiting
NCT04846127ElutiaCanGaroo Envelope

CanGaroo® Registry Study

Start: May 2021Est. completion: Oct 2024
N/ACompleted
NCT04557111Biotronikremote monitoring

Remote Care for CIED Patients in Korea

Start: Jan 2021Est. completion: Dec 2022102 patients
N/ACompleted
NCT04471584Rhythm PharmaceuticalsInsertion of ILR device

Comparative Analysis in Detection of Atrial Arrhythmia and ECG Quality in Three Different Insertable Cardiac Monitors

Start: Sep 2020Est. completion: Mar 2022150 patients
N/AUnknown
NCT02746471Rhythm PharmaceuticalsReveal LINQ

Reveal LINQ Registry

Start: Apr 2014Est. completion: Jun 20211,604 patients
N/ACompleted
NCT01168427Rhythm PharmaceuticalsReveal® DX or Reveal® XT Insertable Cardiac Monitor

Reveal In-Office Implants

Start: Aug 2010Est. completion: May 201166 patients
N/ACompleted
NCT01000532BiotronikSIELLO JT/T

SIELLO Pilot Study for Comparison of Steroid Versus Non-Steroid Pacing Leads

Start: Oct 2009Est. completion: Feb 201188 patients
N/ACompleted

Related Jobs in Cardiovascular

Embedded Software and System Test Engineer (H/F)

Cardiawave
Levallois-Perret, France (Hybrid)
Just now

Territory Sales Manager - Iowa / Nebraska

HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
19h ago
From $150K/yr

Clinical Consultant

Johnson & Johnson
North Ryde, New South Wales, Australia
20h ago

Regional Sales Specialist (Orange County / Long Beach, CA) - Johnson & Johnson MedTech, Electrophysiology

Johnson & Johnson
Irvine, California, United States of America
20h ago
$100K - $135K/yr

Trainee Technical Specialist

Johnson & Johnson
Leeds, West Yorkshire, United Kingdom
20h ago

Ingénieur d'Application Clinique (H/F) Dept. 54, 57, 67, 68, 25, 90

Johnson & Johnson
Issy-les-Moulineaux, France
20h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 3,320 patients
5 companies competing in this space

Related Indications

Heart Failure(334)Hypertension(333)Coronary Artery Disease(295)Atrial Fibrillation(288)Pulmonary Arterial Hypertension(103)Acute Coronary Syndrome(62)Pulmonary Hypertension(55)Essential Hypertension(32)Coronary Heart Disease(28)Aortic Valve Stenosis(27)